Rizmoic is a medicine for treating constipation caused by opioid pain relief medicines in patients who have previously been treated with a laxative (a medicine that triggers bowel movements). It contains the active substance naldemedine.
Therapeutic Indication
### Therapeutic indication Rizmoic is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have previously been treated with a laxative.
Therapeutic Area (MeSH)
N/AATC Code
A06AH05
ATC Item
naldemedine
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| naldemedine tosilate | N/A | naldemedine tosilate |
| Naldemedine tosilate | N/A | naldemedine tosilate |
EMA Name
Rizmoic
Medicine Name
Rizmoic
Aliases
N/ANo risk management plan link.
